Variables | Groups | Seroprevalence | P-valuea | |
---|---|---|---|---|
Number of examinated patients (%) | Number of positive patients (%) | |||
Sex | Female | 275 (73.5) | 23 (8.4) | 0.484b |
Male | 99 (26.5) | 9 (9.1) | ||
Total | 374 (100.0) | 32 (8.6) | ||
Age (years) | 0–9 | 23 (7.2) | 2 (8.7) | 0.782 |
10–19 | 34 (10.6) | 4 (11.8) | ||
20–29 | 54 (16.9) | 4 (7.4) | ||
30–39 | 56 (17.5) | 5 (8.9) | ||
40–49 | 41 (12.8) | 1 (2.4) | ||
50–59 | 50 (15.6) | 7 (14.0) | ||
60–69 | 29 (9.1) | 2 (6.9) | ||
70–79 | 21 (6.6) | 1 (4.8) | ||
80–89 | 12 (3.8) | 4 (33.3) | ||
Total | 320 (100.0) | 30 (9.4) | ||
District | Tataouine Nord | 190 (50.8) | 19 (10.0) | 0.176 |
Tataouine Sud | 142 (38.0) | 11 (7.7) | ||
Smâr | 4 (1.1) | 0 (0) | ||
Remada | 28 (7.5) | 1 (3.6) | ||
Bir Lahmar | 3 (0.8) | 0 (0) | ||
Ghomrassen | 7 (1.9) | 1 (14.3) | ||
Total | 374 (100.0) | 32 (8.6) |